Sequence polymorphisms of the mitochondrial displacement loop and outcome of non-small cell lung cancer

Experimental and Therapeutic Medicine

Volumn 3, Issue 5, 2012, Pages 861-864

  Ding, Cuimin ^a   Li, Ruijuan ^a   Wang, Ping ^a   Fan, Haiyan ^a   Guo, Zhanjun ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Displacement loop; Mitochondrial DNA; Non small cell lung cancer; Outcome; Single nucleotide polymorphism

Indexed keywords

MITOCHONDRIAL DNA;

ADULT; ALLELE; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; DISPLACEMENT LOOP; DNA SEQUENCE; DNA STRUCTURE; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTIVE VALUE; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE; SURVIVAL TIME;

EID: 84863380487     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.490     Document Type: Article

References (34)

1. Parkin DM, Bray FI and Devesa SS: Cancer burden in the year 2000. The global picture. Eur J Cancer 37 (Suppl 8): S4-S66, 2001.
2. Cao C, Zhang YM, Wang R, Sun SF, Chen ZB, Ma HY, Yu YM, Ding QL, Shu LH and Deng ZC: Excision repair cross complementation group 1 polymorphisms and lung cancer risk: a meta-analysis. Chin Med J (Engl) 124: 2203-2208, 2011.
3. Yang L, Yang G, Zhou M, Smith M, Ge H, Boreham J, Hu Y, Peto R, Wang J and Chen Z: Body mass index and mortality from lung cancer in smokers and nonsmokers: a nationally representative prospective study of 220,000 men in China. Int J Cancer 125: 2136-2143, 2009.
4. Gandara D, Narayan S, Lara PN Jr, Goldberg Z, Davies A, Lau DH, Mack P, Gumerlock P and Vijayakumar S: Integration of novel therapeutics into combined modality therapy of locally advanced non-small cell lung cancer. Clin Cancer Res 11: 5057s-5062s, 2005.
5. Yin M, Liao Z, Huang YJ, Liu Z, Yuan X, Gomez D, Wang LE and Wei Q: Polymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapy. PLoS One 6: e20055, 2011.
6. Yang P, Allen MS, Aubry MC, Wampfler JA, Marks RS, Edell ES, Thibodeau S, Adjei AA, Jett J and Deschamps C: Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. Chest 128: 452-462, 2005.
7. Cullen MH, Billingham LJ, Woodroffe CM, Chetiyawardana AD, Gower NH, Joshi R, Ferry DR, Rudd RM, Spiro SG, Cook JE, et al: Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life. J Clin Oncol 17: 3188-3194, 1999.
8. Bi N, Yang M, Zhang L, Chen X, Ji W, Ou G, Lin D and Wang L: Cyclooxygenase-2 genetic variants are associated with survival in unresectable locally advanced non-small cell lung cancer. Clin Cancer Res 16: 2383-2390, 2010.
9. Gupta A, Srivastava S, Prasad R, Natu SM, Mittal B, Negi MP and Srivastava AN: Oxidative stress in non-small cell lung cancer patients after chemotherapy: association with treatment response. Respirology 15: 349-356, 2010.
10. Loft S, Svoboda P, Kawai K, Kasai H, Sørensen M, Tjønneland A, Vogel U, Møller P, Overvad K and Raaschou-Nielsen O: Association between 8-oxo-7,8-dihydroguanine excretion and risk of lung cancer in a prospective study. Free Radic Biol Med: Oct. 20, 2011 (E-pub ahead of print).
11. Lawless MW, O'Byrne KJ and Gray SG: Oxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy. J Cell Mol Med 13: 2800-2821, 2009.
12. Shadel GS and Clayton DA: Mitochondrial DNA maintenance in vertebrates. Annu Rev Biochem 66: 409-435, 1997.
13. DiMauro S and Schon EA: Mitochondrial DNA mutations in human disease. Am J Med Genet 106: 18-26, 2001.
14. Beal MF: Mitochondia, free radicals, and neurodegeneration. Curr Opin Neurobiol 6: 661-666, 1996.
15. Lightowlers RN, Chinnery PF, Turnbull DM, and Howell N: Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends Genet 13: 450-455, 1997.
16. Wallace DC: Mouse models for mitochondrial disease. Am J Med Genet 106: 71-93, 2001.
17. Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, Jen J and Sidransky D: Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287: 2017-2019, 2000.
18. Nomoto S, Yamashita K, Koshikawa K, Nakao A and Sidransky D: Mitochondrial D-loop mutation as clonal markers in multicentric hepatocellular carcimona and plasma. Clin Cancer Res 8: 481-487, 2002.
19. Mambo E, Gao X, Cohen Y, Guo Z, Talalay P and Sidransky D: Electrophile and oxidant damage of mitochondrial DNA leading to rapid evolution of homoplasmic mutations. Proc Natl Acad Sci USA 100: 1838-1843, 2003.
20. Yoneyama H, Hara T, Kato Y, Yamori T, Matsuura ET and Koike K: Nucleotide sequence variation is frequent in the mitochondrial DNA displacement loop region of individual human tumor cells. Mol Cancer Res 3: 14-20, 2005.
21. Jakupciak JP, Maragh S, Markowitz ME, Greenberg AK, Hoque MO, Maitra A, Barker PE, Wagner PD, Rom WN, Srivastava S, Sidransky D and O'Connell CD: Performance of mitochondrial DNA mutations detecting early stage cancer. BMC Cancer 8: 285, 2008.
22. Nashikawa M, Nishiguchi S, Shiomi S, Tamori A, Koh N, Takeda T, Kubo S, Hirohashi K, Kinoshita H, Sato E and Inoue M: Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma. Cancer Res 61: 1843-1845, 2001.
23. Sanchez-Cespedes M, Parrella P, Nomoto S, Cohen D, Xiao Y, Esteller M, Jeronimo C, Jordan RC, Nicol T and Koch WM: Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res 61: 7015-7019, 2001.
24. Taanman JW: The mitochondrial genome: structure, transcription, translation and replication. Biochim Biophys Acta 1410: 103-123, 1999.
25. Zhang R, Zhang F, Wang C, Wang S, Shiao YH and Guo Z: Identification of sequence polymorphism in the D-loop region of mitochondrial DNA as a risk factor for hepatocellular carcinoma with distinct etiology. J Exp Clin Cancer Res 29: 130, 2010.
26. Wang C, Zhang F, Fan H, Peng L, Zhang R, Liu S and Guo Z: Sequence polymorphisms of mitochondrial D-loop and hepatocellular carcinoma outcome. Biochem Biophys Res Commun 406: 493-496, 2011.
27. Navaglia F, Basso D, Fogar P, Sperti C, Greco E, Zambon CF, Stranges A, Falda A, Pizzi S, Parenti A, Pedrazzoli S and Plebani M: Mitochondrial DNA D-loop in pancreatic cancer: somatic mutations are epiphenomena while the germline 16519 T variant worsens metabolism and outcome. Am J Clin Pathol 126: 593-601, 2006.
28. Wang L, Bamlet WR, de Andrade M, Boardman LA, Cunningham JM, Thibodeau SN and Petersen GM: Mitochondrial genetic polymorphisms and pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev 16: 1455-1459, 2007.
29. Wang L, McDonnell SK, Hebbring SJ, Cunningham JM, St Sauver J, Cerhan JR, Isaya G, Schaid DJ and Thibodeau SN: Polymorphisms in mitochondrial genes and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 17: 3558-3566, 2008.
30. Zhang R, Wang R, Zhang F, Wu C, Fan H, Li Y, Wang C and Guo Z: Single-nucleotide polymorphisms in the mitochondrial displacement loop and outcome of esophageal squamous cell carcinoma. J Exp Clin Cancer Res 29: 155, 2010.
31. Bandy B and Davison AJ: Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging? Free Radic Biol Med 8: 523-539, 1990.
32. Gille JJ and Joenje H: Cell culture models for oxidative stress: superoxide and hydrogen peroxide versus normobaric hyperoxia. Mutat Res 275: 405-414, 1992.
33. Shigenaga MK, Hagen TM and Ames BN: Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA 91: 10771-10778, 1994.
34. Dement GA, Maloney SC and Reeves R: Nuclear HMGA1 nonhistone chromatin proteins directly influence mitochondrial transcription, maintenance, and function. Exp Cell Res 313: 77-87, 2007.